Let’s assume someone would send you $100m tomorrow with just one instruction: “advance the Biostasis field as much as possible”. I think it’s not obvious what would be the most prudent use of the funds. …

(work in progress, we will continuously extent this list) R&D is at the core of Tomorrow’s mission. In fact one of our primary long-term goals is to be able to continuously conduct and fund R&D — the other is providing the very best cryopreservation to our members. Growing is not…

Over the last year we’ve built a strong team for Tomorrow Biostasis. All of our core responsibilities are covered and we’ve been operational for a while. Now we’re starting with the second phase of building and scaling the company — and hiring is one of the most important parts. We…

It might take decades or even centuries until it becomes clear if a new technology will have changed the world for the better or worse. While this uncertainty has rarely — if ever — hindered progress in the long run, it is still prudent to think about what effects might be…

Dec 31, 2019 was the last day as CEO of my last company Medlanes (now exited to Zava). I’ve been running Tomorrow Biostasis for a bit more than a year now. It’s a good time to look back for the first time. Tomorrow Biostasis is part of a larger mission…

TL;DR: Almost 40% of the “internet population” is interested in signing up for Biostasis, a much bigger opportunity that currently captured. Market education is not needed, capturing the interest is the key. — There are very few things you can think of, that just a bit over 3,000 people worldwide…

Two hundred years ago, the average human life span was ≈40. A century ago, it was 55. Now, it’s right around 80 (1). Today, if someone dies at the age of 55, it is considered a tragedy, and everyone agrees that they went “before their time”. Dying at the age of 85+…